Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.

Fornes, P; Richer, C; Vacher, E; Bruneval, P; Giudicelli, J F

Fornes, P; Richer, C; Vacher, E; Bruneval, P; Giudicelli, J F.

Affiliation

Fornes P; Département de Pharmacologie, Faculté de Médecine Paris-Sud, France.

J Cardiovasc Pharmacol ; 22(2): 305-13, 1993 Aug.

Article in En | MEDLINE | ID: mdl-7692174

Subject(s)

Angiotensin Receptor Antagonists; Antihypertensive Agents/therapeutic use; Biphenyl Compounds/therapeutic use; Cerebrovascular Disorders/genetics; Hypertension/drug therapy; Imidazoles/therapeutic use; Substance Withdrawal Syndrome/prevention & control; Tetrazoles/therapeutic use; Aging/physiology; Animals; Blood Pressure/drug effects; Body Weight/drug effects; Brain/pathology; Diuresis/drug effects; Heart Rate/drug effects; Hypertension/pathology; Kidney/pathology; Losartan; Male; Myocardium/pathology; Proteinuria/prevention & control; Rats; Rats, Inbred SHR; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Substance Withdrawal Syndrome / Tetrazoles / Biphenyl Compounds / Cerebrovascular Disorders / Angiotensin Receptor Antagonists / Hypertension / Imidazoles / Antihypertensive Agents Limits: Animals Language: En Journal: J Cardiovasc Pharmacol Year: 1993 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links